AU2020239014A1 - Systems and methods for drug-agnostic patient-specific dosing regimens - Google Patents

Systems and methods for drug-agnostic patient-specific dosing regimens Download PDF

Info

Publication number
AU2020239014A1
AU2020239014A1 AU2020239014A AU2020239014A AU2020239014A1 AU 2020239014 A1 AU2020239014 A1 AU 2020239014A1 AU 2020239014 A AU2020239014 A AU 2020239014A AU 2020239014 A AU2020239014 A AU 2020239014A AU 2020239014 A1 AU2020239014 A1 AU 2020239014A1
Authority
AU
Australia
Prior art keywords
patient
drug
drugs
dosing regimen
model
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020239014A
Other languages
English (en)
Inventor
Diane R. Mould
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2019/028750 external-priority patent/WO2019209845A1/en
Application filed by Individual filed Critical Individual
Publication of AU2020239014A1 publication Critical patent/AU2020239014A1/en
Priority to AU2025275175A priority Critical patent/AU2025275175A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Databases & Information Systems (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2020239014A 2019-03-08 2020-03-09 Systems and methods for drug-agnostic patient-specific dosing regimens Abandoned AU2020239014A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2025275175A AU2025275175A1 (en) 2019-03-08 2025-12-03 Systems and methods for drug-agnostic patient-specific dosing regimens

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962815825P 2019-03-08 2019-03-08
US62/815,825 2019-03-08
PCT/US2019/028750 WO2019209845A1 (en) 2018-04-23 2019-04-23 Systems and methods for modifying adaptive dosing regimens
US16/391,950 US20190326002A1 (en) 2018-04-23 2019-04-23 Systems and methods for modifying adaptive dosing regimens
AUPCT/US2019/028750 2019-04-23
US16/391,950 2019-04-23
PCT/US2020/021742 WO2020185699A1 (en) 2019-03-08 2020-03-09 Systems and methods for drug-agnostic patient-specific dosing regimens

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2025275175A Division AU2025275175A1 (en) 2019-03-08 2025-12-03 Systems and methods for drug-agnostic patient-specific dosing regimens

Publications (1)

Publication Number Publication Date
AU2020239014A1 true AU2020239014A1 (en) 2021-10-07

Family

ID=72426742

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2020239014A Abandoned AU2020239014A1 (en) 2019-03-08 2020-03-09 Systems and methods for drug-agnostic patient-specific dosing regimens
AU2025275175A Pending AU2025275175A1 (en) 2019-03-08 2025-12-03 Systems and methods for drug-agnostic patient-specific dosing regimens

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2025275175A Pending AU2025275175A1 (en) 2019-03-08 2025-12-03 Systems and methods for drug-agnostic patient-specific dosing regimens

Country Status (8)

Country Link
EP (1) EP3935639A1 (cg-RX-API-DMAC7.html)
JP (2) JP7618239B2 (cg-RX-API-DMAC7.html)
KR (1) KR102839034B1 (cg-RX-API-DMAC7.html)
AU (2) AU2020239014A1 (cg-RX-API-DMAC7.html)
CA (1) CA3132823A1 (cg-RX-API-DMAC7.html)
IL (1) IL286145A (cg-RX-API-DMAC7.html)
SG (1) SG11202109704UA (cg-RX-API-DMAC7.html)
WO (1) WO2020185699A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12064664B2 (en) 2020-11-10 2024-08-20 Willowview Consulting, Llc Method and system for dynamically transforming user health and exercise-related data into visual, audio, textual, and physical data representations
US20220199266A1 (en) * 2020-12-10 2022-06-23 DataRobot, Inc. Systems and methods for using machine learning with epidemiological modeling
CN113643785B (zh) * 2021-07-22 2023-09-01 海南大学 基于dikw图谱的疫苗接种浓度确认方法
JP2023127482A (ja) * 2022-03-01 2023-09-13 株式会社島津製作所 試料分析装置、試料分析方法、医薬分析装置および医薬分析方法
CN114765076A (zh) * 2022-04-18 2022-07-19 柳州市妇幼保健院 新生儿个体化氟康唑给药量计算方法及给药方案推荐系统
KR102834065B1 (ko) * 2022-09-22 2025-07-16 서울대학교산학협력단 약동학적 변화량 예측 장치 및 방법
CN116453669B (zh) * 2023-06-14 2023-08-25 武汉大学中南医院 一种基于大数据的护理预测方法及装置
WO2025006459A1 (en) * 2023-06-29 2025-01-02 Prxcision, Inc. Machine learning for real-time decision support
CN118016237A (zh) * 2024-01-22 2024-05-10 南栖仙策(南京)高新技术有限公司 给药剂量确定方法、装置、电子设备及存储介质
CN120448609B (zh) * 2025-07-11 2025-09-16 上海斯丹姆医药开发有限责任公司 一种流感疫苗临床试验中的数据可视化方法及系统

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040023211A1 (en) * 2000-09-15 2004-02-05 Kees Groen System and method for optimizing drug theraphy for the treatment of diseases
EP2171630A1 (en) * 2007-06-27 2010-04-07 F. Hoffmann-Roche AG System and method for developing patient specific therapies based on modeling of patient physiology
US20130191097A1 (en) * 2010-01-04 2013-07-25 Mayo Foundation For Medical Education And Research Erythropoietic stimulating agent (esa) dosage determination
US20130041683A1 (en) 2010-04-07 2013-02-14 Novacare Computer based system for predicting treatment outcomes
WO2014055978A1 (en) 2012-10-05 2014-04-10 Baysient LLC System and method for providing patient-specific dosing as a function of mathematical models
US11501863B2 (en) 2015-04-09 2022-11-15 Diane R. MOULD Systems and methods for patient-specific dosing
JP2018190244A (ja) * 2017-05-09 2018-11-29 塩野義製薬株式会社 生理学的モデルによる新規ヒト血漿中濃度推移の予測法

Also Published As

Publication number Publication date
KR20220002884A (ko) 2022-01-07
AU2025275175A1 (en) 2026-01-15
JP2022524083A (ja) 2022-04-27
CA3132823A1 (en) 2020-09-17
JP7618239B2 (ja) 2025-01-21
WO2020185699A1 (en) 2020-09-17
SG11202109704UA (en) 2021-10-28
KR102839034B1 (ko) 2025-07-28
EP3935639A1 (en) 2022-01-12
JP2025020335A (ja) 2025-02-12
IL286145A (en) 2021-10-31

Similar Documents

Publication Publication Date Title
US20240371491A1 (en) Systems and methods for drug-agnostic patient-specific dosing regimens
JP7618239B2 (ja) 薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法
AU2024278361A1 (en) Systems and methods for modifying adaptive dosing regimens
US20230178203A1 (en) Systems and methods for patient-specific dosing
EP2911642B1 (en) Drug monitoring and regulation systems and methods
Chen et al. OrderRex: clinical order decision support and outcome predictions by data-mining electronic medical records
US10262112B2 (en) Prescription decision support system and method using comprehensive multiplex drug monitoring
Al Faysal et al. An explainable machine learning framework for predicting the risk of buprenorphine treatment discontinuation for opioid use disorder among commercially insured individuals
EP3203911A1 (en) Personalized antibiotic dosing platform
JP2024527230A (ja) モノクローナル抗体ノモグラムのためのシステムおよび方法
HK40079892A (en) Systems and methods for patient-specific dosing

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted